University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Peter Stock, M.D.

Transplant surgeon

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants and is co-director of the Pancreatic Islet Cell Transplant Program. Stock was trained at the University of Minnesota, completing a surgical internship and residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.

Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies. In his research, he studies the mechanisms of allograft rejection, chimerism (anti-rejection therapy using the donor's bone marrow cells) and pancreatic islet cell transplantation.

Conditions & Treatments

Clinics

Connie Frank Transplant Center at UCSF
400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143
Phone: (415) 353-1551
Phone: (888) 894-6361
Pre-Kidney Fax: (415) 353-8708
Post-Kidney Fax: (415) 353-8381

Hours: 8 a.m. – 5 p.m.

Liver Transplant Program
400 Parnassus Ave., Sixth Floor
San Francisco, CA 94143
Phone: (415) 353-1888
Fax: (415) 353-8917

Hours: Pre-Liver Transplant Clinic Monday, Tuesday 7 a.m. – 12 p.m.
Hours: Post-Liver Transplant Clinic Tuesday 8 a.m. – 12 p.m.

Pancreas Transplant Services
400 Parnassus Ave., Seventh Floor
San Francisco, CA 94143
Phone: (415) 353-1551
Pre-Pancreas Transplant Fax: (415) 353-8708,
Post-Pancreas Transplant Fax: (415) 353-4183

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Peter Stock

Education

University of Illinois School of Medicine 1982

Residencies

University of Minnesota Medical Center, General Surgery 1990

Fellowships

UCSF Medical Center, Transplant Surgery 1992

Selected Research and Publications

  1. Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK. Development of organ-specific donor risk indices. Liver Transpl. 2012 Apr; 18(4):395-404.
  2. Vu LT, Baxter-Lowe LA, Garcia J, McEnhill M, Summers P, Hirose R, Lee M, Stock PG. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Arch Surg. 2011 Jul; 146(7):824-9.
  3. Stock P, Kirk AD. The risk and opportunity of homeostatic repopulation. Am J Transplant. 2011 Jul; 11(7):1349-50.
  4. Reich DJ, Magee JC, Gifford K, Merion RM, Roberts JP, Klintmalm GB, Stock PG. Transplant surgery fellow perceptions about training and the ensuing job market-are the right number of surgeons being trained? Am J Transplant. 2011 Feb; 11(2):253-60.
  5. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation. 2010 Dec 27; 90(12):1595-601.
  6. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
  7. Wiseman AC, Wainright JL, Sleeman E, McBride MA, Baker T, Samana C, Stock P. An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation. 2010 Sep 15; 90(5):475-80.
  8. Singh AK, Stock P, Akbari O. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy. 2011 Feb; 66(2):155-62.
  9. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant. 2010 Aug; 10(8):1870-80.
  10. Coffin CS, Stock PG, Dove LM, Berg CL, Nissen NN, Curry MP, Ragni M, Regenstein FG, Sherman KE, Roland ME, Terrault NA. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant. 2010 May; 10(5):1268-75.
  11. Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O. Kidney transplantation at UCSF: 8,300 transplants and onward. Clin Transpl. 2010; 161-7.
  12. Posselt AM, Szot GL, Frassetto LA, Masharani U, Stock PG. Clinical islet transplantation at the University of California, San Francisco. Clin Transpl. 2010; 235-43.
  13. Mukhtar RA, Baskin LS, Stock PG, Lee H. Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence. J Pediatr Surg. 2009 Dec; 44(12):e31-3.
  14. Blumberg EA, Stock P. Solid organ transplantation in the HIV-infected patient. Am J Transplant. 2009 Dec; 9 Suppl 4:S131-5.
  15. Tan-Tam CC, Frassetto LA, Stock PG. Liver and kidney transplantation in HIV-infected patients. AIDS Rev. 2009 Oct-Dec; 11(4):190-204.
  16. Frassetto LA, Tan-Tam C, Stock PG. Renal transplantation in patients with HIV. Nat Rev Nephrol. 2009 Oct; 5(10):582-9.
  17. Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, Dove L, Roland M, Florman S, Blumberg E, Stosor V, Jayaweera DT, Huprikar S, Fung J, Pruett T, Stock P, Ragni M. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64.
  18. Szot GL, Lee MR, Tavakol MM, Lang J, Dekovic F, Kerlan RK, Stock PG, Posselt AM. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation. 2009 Sep 27; 88(6):753-6.
  19. Tilney N, Murray J, Thistlethwaite R, Norman D, Delmonico F, Hanto D, Leichtman A, Danovitch G, Sayegh M, Shapiro R, Harmon W, Salvatierra O, Brennan D, McDiarmid S, Stock P, Pomfret L, Bennett W, Conti D, Metzger B, Sarwal M, Cosimi AB. Promotion of altruistic donation. Transplantation. 2009 Sep 27; 88(6):847.
  20. Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, Umetsu DT, Dekruyff RH. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol. 2010 Jan; 3(1):81-91.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.